CAAA's-ATI Pharm Flashcards
CAAA’s stand for
Centrally acting alpha antagonists
Meds
Prototype=Clonidine
- guanfacine
- methyldopa
Expected pharm action
Act within CNS to decreases sympathetic outflow resulting in decreased stimulation of the andrenergic receptors(alpha and beta) of the heart and peripheral vascular system
- decrease in sympathetic outflow to myocardium results in bradycardia and decreased cardiac output(CO)
- decrease in sympathetic outflow to peripheral vasculature results in vasodilation, which leads to decreased BP
Therapeutic uses
1-primary hypertension(alone or in combo w/diuretic or another antihypertensive agent
2-severe cancer pain(parenterally by epidural infusion)
Investigational=
1-migraines,2-menopause flushing,3-ADHD/tourettes,4-withdrawal from alcohol,tobacco,opioids
Complications
1-drowsiness&sedation
2-dry mouth(resolves in 2-4 wks)
3-rebound hypertension if abruptly discontinued=don’t discontinue w/o talking to provider,discontinue clonidine gradually over 2 to 4 days
Contraindications/precautions
Pregnancy Risk Cat
Clonidine=C;Methyldopa/Guanfacine=B
1-avoid use during lactation
2-avoid use of transdermal patch on affected skin in scleroderma/lupus
-Contraindicated in pts who have bleeding disorder/on anticoagulants
-use caution on pts who have had a stroke,asthma,COPD,recent MI,diabetes,major depressive disorder or chronic kidney disease
Interactions
1-antihypertensive meds=additive effect
2-Prazosin/MAOI’s,tricyclic antidepressants=can counteract antihypertensive effect of Clonidine
3-CNS depressants such as alcohol=additive CNS depression can occur
Nursing admin
1-oral,epidural,transdermal
2-twice a day in divided doses, take larger dose at bedtime
3-transdermal patches applied every 7 days on torso/upper arm